discontinued

PA1192XC Menopausal Gonadotropin

Search for all "Menopausal Gonadotropin"

10 mg / €400.00

Quick Overview

Menopausal Gonadotropin

PA1192XC

Product Description for Menopausal Gonadotropin

Menopausal Gonadotropin.
Presentation: Purified

Properties for Menopausal Gonadotropin

Product Category Proteins & Growth Factors
Quantity 10 mg
Presentation Purified
Source Urine
Species (Protein) Human
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Proteins (de)

Datasheet Extract

Purity > 98 % Greater than 98.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Anion-exchange FPLC.
(c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
Add. information Free of: HbsAg, Hepatitis B surface antigen and antibodies to HIV, Hepatitis C and HCV.
Protein quantitation was carried out by two independent methods:
1. UV spectroscopy at 280 nm .
2. Analysis by RP-HPLC, using a standard solution of hMG as a Reference Standard.
Concentration 1.0 mg/ml
General Readings
  1. Lin YH, Seow KM, Chen HJ, Huang LW, Hwang JL, Tzeng CR. Impact of estradiol patterns in clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol. Gynecol Endocrinol. 2007 Jan;23(1):45-9. PubMed PMID: 17484512.
  2. Zhang HQ, Yan B, Zhao HX, Gu DY, Jia XF, Cao L, et al. Effect of traditional Chinese herbs combined with low dose human menopausal gonadotropin applied in frozen-thawed embryo transfer. Chin J Integr Med. 2006 Dec;12(4):244-9. PubMed PMID: 17361518.
  3. Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study. Gynecol Endocrinol. 2006 Jun;22(6):297-302. PubMed PMID: 16785154.
  4. Zech NH, Netzbandt P, Zech H. Development of severe ovarian hyperstimulation syndrome after inadvertent stimulation with a gonadotropin-releasing hormone agonist and human menopausal gonadotropin in a pre-existing early pregnancy. Fertil Steril. 2005 Dec;84(6):1745. PubMed PMID: 16359980.
  5. Keye WR, Webster B, Dickey R, Somkuti S, Crain J, Scobey MJ. Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization. Reprod Biol Endocrinol. 2005 Nov 9;3:62. PubMed PMID: 16280073. (Free PMC Article available, 1 images available)
  6. Ov ulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin. Gynecol Endocrinol 2005 Mar;20(3):161-9
Storage Lyophilized hMG although stable at room temperature for 3 weeks, should be stored desiccated below -18 C. Upon reconstitution hMG should be stored at 4 C between 2-7 days and for future use below -18 C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please avoid freeze-thaw cycles.
Source Urine of post-menopausal women.
Description
Description:
hMG is produced from a sterile preparation of placental glucoprotein urine of post-menopausal women.The hMG is purified by proprietary chromatographic techniques.
Biological activity:
hMG conforms the following activities: 100IU/mg of FSH and 100 IU/mg LH.
Format
Buffer System:
Lyophilized from a concentrated solution in water containing no additives.
Purity:
>98% Greater than 98.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Anion-exchange FPLC.
(c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
State:
Sterile Filtered White lyophilized (freeze-dried) powder.
Purified
Reconstitution:
It is recommended to reconstitute the lyophilized hMG in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.
  • LinkedIn